Letter to the Editor
Lactic Acidosis During Nucleoside Antiretroviral HIV Therapy
Abstract
Morbidity and mortality associated with human immunodeficiency virus (HIV) have decreased with the administration of nucleoside reverse transcriptase inhibitors (NRTIs) in the setting of highly active antiretroviral therapy (HAART). However, the use of NRTIs has been increasingly recognized as a cause of lactic acidosis. We report a case of fatal NRTI-induced lactic acidosis that occurred 4 months after stavudine, didanosine, and tenofovir were initiated.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.